Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription 18.11.2024 2 Am Heart J 1 Am J Ophthalmol 2 Biochem Biophys Res Commun 2 BMJ 7 Diabet Med 4 Diabetes 1 Diabetes Care 8 Diabetes Obes Metab 9 Diabetologia 1 Invest Ophthalmol Vis Sci 5 J Clin Endocrinol Metab 4 J Diabetes Complications 1 JAMA 1 Med J Aust 1 Metabolism 1 N Engl J Med 1 Nutr Metab (Lond) 1 PLoS Genet 10 PLoS One 2 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. HAMID H, Bagheri M, Benzing T, Krishnan S, et al
   Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the Tirzepatide treatment on coronary atherosclerosis progression: The (T-PLAQUE) randomized-controlled trial design: tirzepatide and plaque.
   Am Heart J. 2024 Aug 24:S0002-8703(24)00218-7. doi: 10.1016/j.ahj.2024.
   PubMed         Abstract available
   
   
2. HASSAN S, Chang LS, Gabovitch D, Chasse J, et al
   Enrollment strategies in the era of digital revolution: Experience from a remote health management program.
   Am Heart J. 2024;278:181-185.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

3. ENG K, Zebardast N, Boland MV, Lo JE, et al
   Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes.
   Am J Ophthalmol. 2024 Nov 6:S0002-9394(24)00506.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

4. ISHII R, Ohnishi S, Hojo M, Ishikawa K, et al
   Hypoxic culture enhances the antimicrobial activity of amnion-derived mesenchymal stem cells, thereby reducing bacterial load and promoting wound healing in diabetic mice.
   Biochem Biophys Res Commun. 2024;739:150903.
   PubMed         Abstract available
   
   
5. CHEN X, Yang C, Wei Q, Huang M, et al
   A novel mutation in HNF1B promotes ferroptosis-mediated renal mesangial cells fibrosis.
   Biochem Biophys Res Commun. 2024;736:150803.
   PubMed         Abstract available
   
   

   
   BMJ

6. IACOBUCCI G
   Diabetes: Global treatment gap is widening, study finds.
   BMJ. 2024;387:q2515.
   PubMed        
   
   
7. SCIVIER M
   Quality care is needed for older people with diabetes in care homes-now and for the future.
   BMJ. 2024;387:q2471.
   PubMed        
   
   

   
   Diabet Med

8. DONIS R, Patel KA, Wakeling MN, Johnson MB, et al
   A homozygous TARS2 variant is a novel cause of syndromic neonatal diabetes.
   Diabet Med. 2024 Nov 7:e15471. doi: 10.1111/dme.15471.
   PubMed         Abstract available
   
   
9. MOHAMED S, Avenell A, Douglas F, Keen A, et al
   Investigating health professionals' perspectives and experiences of food security-related conversations in diabetes care.
   Diabet Med. 2024 Nov 9:e15470. doi: 10.1111/dme.15470.
   PubMed         Abstract available
   
   
10. NIWAHA AJ, Shields BM, Rodgers LR, Hattersley AT, et al
    The impact of prolonged walking on fasting plasma glucose in type 2 diabetes: A randomised controlled crossover study.
    Diabet Med. 2024 Nov 9:e15468. doi: 10.1111/dme.15468.
    PubMed         Abstract available
    
    
11. FAN KS, Manoli A, Shojaee-Moradie F, Hutchison E, et al
    The practical operation and consequences of glucose measurement by pilots with diabetes.
    Diabet Med. 2024 Nov 9:e15472. doi: 10.1111/dme.15472.
    PubMed        
    
    
12. GUNABALASINGAM S, Kyrka A, Hopkins L, Lebrett R, et al
    Interventions in women with type 2 diabetes mellitus in the pre-pregnancy, pregnancy and postpartum periods to optimise care and health outcomes: A systematic review.
    Diabet Med. 2024 Nov 11:e15474. doi: 10.1111/dme.15474.
    PubMed         Abstract available
    
    
13. DALSGAARD EM, Graversen SB, Bjerg L, Sandbaek A, et al
    Diabetes distress and depression in type 2 diabetes. A cross-sectional study in 18,000 individuals in the Central Denmark region.
    Diabet Med. 2024 Nov 12:e15463. doi: 10.1111/dme.15463.
    PubMed         Abstract available
    
    
14. TANG TS, Klein G, Gorges M, Yip A, et al
    Evaluating a mental health support mobile app for adults with type 1 diabetes living in rural and remote communities: The REACHOUT pilot study.
    Diabet Med. 2024 Nov 13:e15451. doi: 10.1111/dme.15451.
    PubMed         Abstract available
    
    

    
    Diabetes

15. YUAN S, Yu Q, Luo M, Wu J, et al
    Friend or foe: the paradoxical roles of MG53 in diabetes mellitus.
    Diabetes. 2024 Nov 13:db240556. doi: 10.2337/db24-0556.
    PubMed         Abstract available
    
    
16. LUCKETT AM, Hawkes G, Green HD, De Franco E, et al
    Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes.
    Diabetes. 2024 Nov 12:db240485. doi: 10.2337/db24-0485.
    PubMed         Abstract available
    
    
17. CARTER EB
    Innovating Diabetes Care in Pregnancy: Do group care models improve outcomes and equity?
    Diabetes. 2024 Nov 12:dbi240006. doi: 10.2337/dbi24-0006.
    PubMed         Abstract available
    
    
18. RAJESH LENIN R, Monickaraj F
    Comment on Yang et al. Deciphering the Connection Between Microvascular Damage and Neurodegeneration in Early Diabetic Retinopathy. Diabetes 2024;73:1883-1894.
    Diabetes. 2024 Nov 11:db240629. doi: 10.2337/db24-0629.
    PubMed        
    
    

    
    Diabetes Care

19. YI Y, Guo C, Zheng Y, Chen S, et al
    Life Course Associations Between Ambient Fine Particulate Matter and the Prevalence of Prediabetes and Diabetes: A Longitudinal Cohort Study in Taiwan and Hong Kong.
    Diabetes Care. 2024 Nov 12:dc241041. doi: 10.2337/dc24-1041.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. MILDER TY, Lin J, Pearson SA, de Oliveira Costa J, et al
    Discontinuation of SGLT2i in people with type 2 diabetes following hospitalisation for heart failure: A cause for concern?
    Diabetes Obes Metab. 2024 Nov 7. doi: 10.1111/dom.16061.
    PubMed        
    
    
21. GREGORIC N, Sikonja J, Janez A, Jensterle M, et al
    Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism.
    Diabetes Obes Metab. 2024 Nov 7. doi: 10.1111/dom.16042.
    PubMed         Abstract available
    
    
22. GETHER IM, Andersen ES, Foghsgaard S, Ellegaard AM, et al
    Increased gallbladder emptying and reduced GLP-1 response in pregnancy with and without gestational diabetes mellitus.
    Diabetes Obes Metab. 2024 Nov 14. doi: 10.1111/dom.16064.
    PubMed         Abstract available
    
    
23. RODRIGUEZ P, Breslaw N, Xiao H, Bena J, et al
    De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: A single-centre, open-label randomised trial (TRANSITION-T2D).
    Diabetes Obes Metab. 2024 Nov 12. doi: 10.1111/dom.16057.
    PubMed         Abstract available
    
    
24. RILEY DR, Henney A, Anson M, Hernadez G, et al
    The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomes.
    Diabetes Obes Metab. 2024 Nov 11. doi: 10.1111/dom.16059.
    PubMed         Abstract available
    
    
25. ZHANG Z, Wang Y, Lu J, Zhou J, et al
    Time in tight range: A key metric for optimal glucose control in the era of advanced diabetes technologies and therapeutics.
    Diabetes Obes Metab. 2024 Nov 11. doi: 10.1111/dom.16033.
    PubMed         Abstract available
    
    
26. MAGAGNOLI J, Cummings TH, Hardin JW, Ambati J, et al
    Targeting the cholinergic anti-inflammatory pathway for type 2 diabetes prevention: A retrospective cohort study.
    Diabetes Obes Metab. 2024 Nov 11. doi: 10.1111/dom.16060.
    PubMed         Abstract available
    
    
27. GOLOMB RC, Tittel SR, Welters A, Karges W, et al
    Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria.
    Diabetes Obes Metab. 2024 Nov 11. doi: 10.1111/dom.16048.
    PubMed         Abstract available
    
    

    
    Diabetologia

28. YU G, Tam CHT, Lim CKP, Shi M, et al
    Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06309.
    PubMed         Abstract available
    
    
29. ROONEY MR, Wallace AS, Echouffo Tcheugui JB, Fang M, et al
    Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06315.
    PubMed         Abstract available
    
    
30. PHILLIPS NE, Mareschal J, Biancolin AD, Sinturel F, et al
    The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices.
    Diabetologia. 2024 Nov 12. doi: 10.1007/s00125-024-06318.
    PubMed         Abstract available
    
    
31. WANG E, Patorno E, Khosrow-Khavar F, Crystal S, et al
    Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013-2019.
    Diabetologia. 2024 Nov 8. doi: 10.1007/s00125-024-06321.
    PubMed         Abstract available
    
    
32. 
    Correction: 60(th) EASD Annual Meeting of the European Association for the Study of Diabetes, Madrid, Spain, 9-13 September 2024. 'Average glucose and HbA(1c) display a nonlinear and variable relationship: implications for clinical practice'.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06294.
    PubMed        
    
    
33. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Increased risk of major adverse cardiovascular events in patients with deep and infected diabetes-related foot ulcers.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06316.
    PubMed         Abstract available
    
    
34. GOTTMANN P, Speckmann T, Stadion M, Chawla P, et al
    Transcriptomic heterogeneity of non-beta islet cells is associated with type 2 diabetes development in mouse models.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06301.
    PubMed         Abstract available
    
    
35. RAO C, Cater DT, Roy S, Xu J, et al
    Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8(+) T cell activity and biomarker during the evolution of type 1 diabetes.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06313.
    PubMed         Abstract available
    
    
36. MA RCW, Tam CHT, Hou Y, Lau ESH, et al
    NT-proBNP improves prediction of cardiorenal complications in type 2 diabetes: the Hong Kong Diabetes Biobank.
    Diabetologia. 2024 Nov 7. doi: 10.1007/s00125-024-06299.
    PubMed         Abstract available
    
    

    
    Invest Ophthalmol Vis Sci

37. YU Y, Chen H, Wang Z, Ye Y, et al
    Exploring the Relationship Between Refractive Errors and Common Chronic Diseases Via Blood Biochemistry Tests: A Large Prospective Cohort Study.
    Invest Ophthalmol Vis Sci. 2024;65:26.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

38. YARDLEY JE, Li Z, Zaharieva DP, Riddell MC, et al
    Sex Differences in Glycemia and Self-Management Strategies for Exercise in an Active Adults Cohort with Type 1 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae792. doi: 10.1210.
    PubMed         Abstract available
    
    
39. FENG Y, Shang B, Yang Y, Zhang D, et al
    Impact of DPP-4 inhibitors on interleukin levels in type 2 diabetes mellitus.
    J Clin Endocrinol Metab. 2024 Nov 8:dgae783. doi: 10.1210.
    PubMed         Abstract available
    
    
40. WANG B, Dhaliwal R, Ewing SK, Schwartz AV, et al
    F2-Isoprostanes Are Associated With Increased Fracture Risk in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Nov 8:dgae788. doi: 10.1210.
    PubMed         Abstract available
    
    
41. PHAM UN, Pryke A, Baskerville T, Griffin A, et al
    Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae787. doi: 10.1210.
    PubMed         Abstract available
    
    
42. CHANG LY, Liao HW, Chen JY, Wu VC, et al
    Enhanced Outcomes in Type 2 Diabetes Patients with Acute Kidney Disease Through Thiazolidinedione.
    J Clin Endocrinol Metab. 2024 Nov 13:dgae796. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

43. PANTAZOPOULOS D, Gouveri E, Rizzo M, Papanas N, et al
    Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?
    J Diabetes Complications. 2024;38:108905.
    PubMed         Abstract available
    
    
44. CHEONG SS, Samah N, Che Roos NA, Ugusman A, et al
    Prognostic value of pulse wave velocity for cardiovascular disease risk stratification in diabetic patients: A systematic review and meta-analysis.
    J Diabetes Complications. 2024;38:108894.
    PubMed         Abstract available
    
    
45. LAWRENCE CM, Smart CE, Fatima A, King BR, et al
    Increased bolus overrides and lower time in range: Insights into disordered eating revealed by insulin pump metrics and continuous glucose monitor data in Australian adolescents with type 1 diabetes.
    J Diabetes Complications. 2024;38:108904.
    PubMed         Abstract available
    
    
46. ROONEY MR, Norby FL, Soliman EZ, Chen LY, et al
    Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study.
    J Diabetes Complications. 2024;38:108903.
    PubMed         Abstract available
    
    

    
    JAMA

47. ANDERER S
    Creatine Likely a Marker, Not a Cause, of Insulin Resistance in Type 2 Diabetes.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22566.
    PubMed        
    
    

    
    Med J Aust

48. TAN C, Williams Z, Islam MA, Kelly R, et al
    Interventions for Aboriginal and Torres Strait Islander people with type 2 diabetes that modify its management and cardiometabolic risk factors: a systematic review.
    Med J Aust. 2024 Nov 10. doi: 10.5694/mja2.52508.
    PubMed         Abstract available
    
    

    
    Metabolism

49. CONGUR I, Mingrone G, Guan K
    Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy.
    Metabolism. 2024 Nov 6:156062. doi: 10.1016/j.metabol.2024.156062.
    PubMed         Abstract available
    
    

    
    N Engl J Med

50. JASTREBOFF AM, le Roux CW, Stefanski A, Aronne LJ, et al
    Tirzepatide for Obesity Treatment and Diabetes Prevention.
    N Engl J Med. 2024 Nov 13. doi: 10.1056/NEJMoa2410819.
    PubMed         Abstract available
    
    

    
    Nutr Metab (Lond)

51. YAZDKHASTI M, Jafarabady K, Shafiee A, Omran SP, et al
    The association between age of menopause and type 2 diabetes: a systematic review and meta-analysis.
    Nutr Metab (Lond). 2024;21:87.
    PubMed         Abstract available
    
    

    
    PLoS Genet

52. GHOLIPOURSHAHRAKI T, Bai Z, Shrestha M, Hjelholt A, et al
    Evaluation of Bayesian Linear Regression models for gene set prioritization in complex diseases.
    PLoS Genet. 2024;20:e1011463.
    PubMed         Abstract available
    
    

    
    PLoS One

53. AL-DWAIRI A, Al-Shboul O, Al-U'datt DGF, Saadeh R, et al
    Effect of poor glycemic control on the prevalence and determinants of anemia and chronic kidney disease among type 2 diabetes mellitus patients in Jordan: An observational cross-sectional study.
    PLoS One. 2024;19:e0313627.
    PubMed         Abstract available
    
    
54. SIX S, Israel D, Bilsen J, Kharagjitsing A, et al
    Insights into cultural and compliance challenges in type 2 diabetes care: A qualitative study of Moroccan and Belgian patients in Belgium.
    PLoS One. 2024;19:e0310800.
    PubMed         Abstract available
    
    
55. FAN X, Cao J, Yan G, Zhao Y, et al
    A protocol for research on the use of acupuncture in the management of diabetic peripheral neuropathy in individuals with type 2 diabetes: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310732.
    PubMed         Abstract available
    
    
56. NDARAWIT W, Ochieng CO, Angwenyi D, Cruz JN, et al
    Discovery of alpha-amylase and alpha-glucosidase dual inhibitors from NPASS database for management of Type 2 Diabetes Mellitus: A chemoinformatic approach.
    PLoS One. 2024;19:e0313758.
    PubMed         Abstract available
    
    
57. AMER A, Ayoub A, Brousseau E, Auger N, et al
    Risk of severe influenza infection in women with a history of pregnancy complications: A longitudinal cohort study.
    PLoS One. 2024;19:e0313653.
    PubMed         Abstract available
    
    
58. QI X, Zhu Z, Luo H, Schwartz MD, et al
    Age at diagnosis of diabetes, obesity, and the risk of dementia among adult patients with type 2 diabetes.
    PLoS One. 2024;19:e0310964.
    PubMed         Abstract available
    
    
59. KAJEMBULA IM, Matheo KI, Simchimba PD, Masasi EH, et al
    Understanding the factors influencing nurses in managing patients with diabetic ketoacidosis in the emergency departments of referral hospitals in Dar es Salaam, Tanzania: A descriptive qualitative study.
    PLoS One. 2024;19:e0310414.
    PubMed         Abstract available
    
    
60. QING W, Qian Y
    Association between systemic immunity-inflammation index and glucose regulation in non-diabetic population: A population-based study from the NHANES (2005-2016).
    PLoS One. 2024;19:e0313488.
    PubMed         Abstract available
    
    
61. BONDZIE EPK, Amarteyfio K, Jahan Y, Balabanova D, et al
    Impact of health systems interventions in primary health settings on type 2 diabetes care and health outcomes among adults in West Africa: A systematic review protocol.
    PLoS One. 2024;19:e0291474.
    PubMed         Abstract available
    
    
62. HOU Y, Li R, Xu Z, Chen W, et al
    Association of METS-IR index with Type 2 Diabetes: A cross-sectional analysis of national health and nutrition examination survey data from 2009 to 2018.
    PLoS One. 2024;19:e0308597.
    PubMed         Abstract available
    
    

    
    Transplantation

63. VINSON AJ, Anzalone AJ, Schissel M, Dai R, et al
    Association of COVID-19 With Risk of Posttransplant Diabetes Mellitus.
    Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005227.
    PubMed         Abstract available
    
    
64. STEWART AG, Kotton CN
    Another Viral Infection Linked to Posttransplant Diabetes Mellitus?
    Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005254.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.